advertisement

Topcon

Coultas S 1

Showing records 1 to 1 | Display all abstracts from Coultas S

95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Korenfeld M; Nichols KK; Goldberg D; Evans D; Sall K; Foulks G; Coultas S; Brazzell K
Cornea 2021; 40: 564-570

Issue 22-2

Change Issue


advertisement

Topcon